Serum KL-6 can distinguish between different phenotypes of severe COVID-19

Hideta Nakamura,Kazuya Miyagi,Mariko Otsuki,Yuri Higure,Naoya Nishiyama,Takeshi Kinjo,Masashi Nakamatsu,Shusaku Haranaga,Masao Tateyama,Jiro Fujita

JOURNAL OF MEDICAL VIROLOGY（2021）

引用 13|浏览1

暂无评分

摘要

We read the article by D'Alessandro Miriana et al. with great interest and appreciate their efforts to evaluate the role of serum Krebs von den Lungen‐6 (KL‐6) as a prognostic biomarker of severe coronavirus disease 2019 (COVID‐19).1 This article is protected by copyright. All rights reserved.

查看译文

关键词

different phenotypes,serum

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要